Banks - Regional
Compare Stocks
5 / 10Stock Comparison
BMRC vs ICE vs FIS vs CME vs JKHY
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
Information Technology Services
Financial - Data & Stock Exchanges
Information Technology Services
BMRC vs ICE vs FIS vs CME vs JKHY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Financial - Data & Stock Exchanges | Information Technology Services | Financial - Data & Stock Exchanges | Information Technology Services |
| Market Cap | $420M | $88.45B | $24.47B | $104.07B | $10.57B |
| Revenue (TTM) | $177M | $12.64B | $10.89B | $6.52B | $2.52B |
| Net Income (TTM) | $47M | $3.30B | $382M | $4.24B | $519M |
| Gross Margin | 76.1% | 61.9% | 38.1% | 86.1% | 44.1% |
| Operating Margin | 29.2% | 38.7% | 17.5% | 64.9% | 26.0% |
| Forward P/E | 11.9x | 19.5x | 7.5x | 23.5x | 21.8x |
| Total Debt | $69M | $20.28B | $4.01B | $3.76B | $0.00 |
| Cash & Equiv. | $225M | $837M | $599M | $4.42B | $102M |
BMRC vs ICE vs FIS vs CME vs JKHY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Bank of Marin Banco… (BMRC) | 100 | 77.5 | -22.5% |
| Intercontinental Ex… (ICE) | 100 | 160.6 | +60.6% |
| Fidelity National I… (FIS) | 100 | 34.0 | -66.0% |
| CME Group Inc. (CME) | 100 | 157.1 | +57.1% |
| Jack Henry & Associ… (JKHY) | 100 | 80.7 | -19.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BMRC vs ICE vs FIS vs CME vs JKHY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BMRC carries the broadest edge in this set and is the clearest fit for growth exposure and defensive.
- Rev growth 51.8%, EPS growth 6.3%
- Beta 0.95, yield 3.9%, current ratio 473.15x
- 51.8% NII/revenue growth vs FIS's 5.4%
- 3.9% yield, 4-year raise streak, vs JKHY's 1.5%
Among these 5 stocks, ICE doesn't own a clear edge in any measured category.
FIS ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.31 vs BMRC's 2.82
- Lower P/E (7.5x vs 21.8x), PEG 0.31 vs 2.16
CME is the clearest fit if your priority is long-term compounding.
- 284.9% 10Y total return vs ICE's 225.3%
- 62.0% margin vs FIS's 3.5%
JKHY is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 32 yrs, beta 0.28, yield 1.5%
- Lower volatility, beta 0.28, current ratio 1.27x
- Beta 0.28 vs BMRC's 0.95
- 17.0% ROA vs FIS's 1.1%, ROIC 21.0% vs 6.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 51.8% NII/revenue growth vs FIS's 5.4% | |
| Value | Lower P/E (7.5x vs 21.8x), PEG 0.31 vs 2.16 | |
| Quality / Margins | 62.0% margin vs FIS's 3.5% | |
| Stability / Safety | Beta 0.28 vs BMRC's 0.95 | |
| Dividends | 3.9% yield, 4-year raise streak, vs JKHY's 1.5% | |
| Momentum (1Y) | +29.7% vs FIS's -35.3% | |
| Efficiency (ROA) | 17.0% ROA vs FIS's 1.1%, ROIC 21.0% vs 6.0% |
BMRC vs ICE vs FIS vs CME vs JKHY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BMRC vs ICE vs FIS vs CME vs JKHY — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CME leads in 1 of 6 categories
JKHY leads 1 • BMRC leads 0 • ICE leads 0 • FIS leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CME leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICE is the larger business by revenue, generating $12.6B annually — 71.5x BMRC's $177M. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to FIS's 3.5%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $177M | $12.6B | $10.9B | $6.5B | $2.5B |
| EBITDAEarnings before interest/tax | $71M | $6.5B | $3.8B | $4.7B | $810M |
| Net IncomeAfter-tax profit | $47M | $3.3B | $382M | $4.2B | $519M |
| Free Cash FlowCash after capex | $32M | $4.3B | $2.8B | $4.4B | $728M |
| Gross MarginGross profit ÷ Revenue | +76.1% | +61.9% | +38.1% | +86.1% | +44.1% |
| Operating MarginEBIT ÷ Revenue | +29.2% | +38.7% | +17.5% | +64.9% | +26.0% |
| Net MarginNet income ÷ Revenue | +24.6% | +26.1% | +3.5% | +62.0% | +20.6% |
| FCF MarginFCF ÷ Revenue | +20.9% | +33.9% | +26.1% | +64.3% | +28.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | +8.2% | — | +8.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +76.7% | +23.1% | +92.3% | +21.4% | +12.5% |
Valuation Metrics
Evenly matched — BMRC and FIS each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 9.5x trailing earnings, BMRC trades at a 85% valuation discount to FIS's 63.0x P/E. Adjusting for growth (PEG ratio), CME offers better value at 1.87x vs ICE's 3.05x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $420M | $88.4B | $24.5B | $104.1B | $10.6B |
| Enterprise ValueMkt cap + debt − cash | $264M | $107.9B | $27.9B | $103.4B | $10.5B |
| Trailing P/EPrice ÷ TTM EPS | 9.55x | 27.06x | 63.00x | 25.70x | 23.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.91x | 19.48x | 7.54x | 23.49x | 21.79x |
| PEG RatioP/E ÷ EPS growth rate | 2.26x | 3.05x | 2.58x | 1.87x | 2.32x |
| EV / EBITDAEnterprise value multiple | 4.92x | 16.71x | 7.66x | 22.96x | 13.53x |
| Price / SalesMarket cap ÷ Revenue | 2.38x | 7.00x | 2.29x | 15.96x | 4.45x |
| Price / BookPrice ÷ Book value/share | 1.05x | 3.08x | 1.76x | 3.60x | 5.01x |
| Price / FCFMarket cap ÷ FCF | 11.38x | 20.62x | 9.97x | 24.82x | 17.97x |
Profitability & Efficiency
JKHY leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
JKHY delivers a 24.0% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $3 for FIS. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to ICE's 0.70x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs CME's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.3% | +11.6% | +2.7% | +15.3% | +24.0% |
| ROA (TTM)Return on assets | +1.2% | +2.3% | +1.1% | +2.2% | +17.0% |
| ROICReturn on invested capital | +8.4% | +7.5% | +6.0% | +10.2% | +21.0% |
| ROCEReturn on capital employed | +2.4% | +9.5% | +6.6% | +3.6% | +22.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 9 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.18x | 0.70x | 0.29x | 0.13x | — |
| Net DebtTotal debt minus cash | -$156M | $19.4B | $3.4B | -$666M | -$102M |
| Cash & Equiv.Liquid assets | $225M | $837M | $599M | $4.4B | $102M |
| Total DebtShort + long-term debt | $69M | $20.3B | $4.0B | $3.8B | $0 |
| Interest CoverageEBIT ÷ Interest expense | 1.02x | 6.53x | 4.64x | 41.55x | 122.37x |
Total Returns (Dividends Reinvested)
Evenly matched — BMRC and CME each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CME five years ago would be worth $16,450 today (with dividends reinvested), compared to $3,685 for FIS. Over the past 12 months, BMRC leads with a +29.7% total return vs FIS's -35.3%. The 3-year compound annual growth rate (CAGR) favors BMRC at 26.2% vs FIS's -2.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.0% | -2.1% | -27.3% | +9.1% | -17.8% |
| 1-Year ReturnPast 12 months | +29.7% | -10.4% | -35.3% | +4.6% | -13.6% |
| 3-Year ReturnCumulative with dividends | +100.8% | +50.8% | -6.6% | +71.4% | -1.0% |
| 5-Year ReturnCumulative with dividends | -13.5% | +43.4% | -63.2% | +64.5% | +0.3% |
| 10-Year ReturnCumulative with dividends | +41.5% | +225.3% | -13.2% | +284.9% | +94.9% |
| CAGR (3Y)Annualised 3-year return | +26.2% | +14.7% | -2.2% | +19.7% | -0.3% |
Risk & Volatility
Evenly matched — BMRC and CME each lead in 1 of 2 comparable metrics.
Risk & Volatility
CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than BMRC's 0.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BMRC currently trades 91.5% from its 52-week high vs FIS's 57.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | 0.33x | 0.76x | -0.30x | 0.28x |
| 52-Week HighHighest price in past year | $28.48 | $189.35 | $82.74 | $329.16 | $193.39 |
| 52-Week LowLowest price in past year | $20.25 | $143.17 | $43.30 | $257.17 | $141.81 |
| % of 52W HighCurrent price vs 52-week peak | +91.5% | +82.5% | +57.1% | +87.1% | +75.5% |
| RSI (14)Momentum oscillator 0–100 | 55.0 | 38.8 | 43.3 | 44.1 | 28.2 |
| Avg Volume (50D)Average daily shares traded | 104K | 3.0M | 5.5M | 2.2M | 902K |
Analyst Outlook
Evenly matched — BMRC and JKHY each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BMRC as "Hold", ICE as "Buy", FIS as "Buy", CME as "Hold", JKHY as "Buy". Consensus price targets imply 42.6% upside for FIS (target: $67) vs 8.4% for BMRC (target: $28). For income investors, BMRC offers the higher dividend yield at 3.89% vs ICE's 1.24%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $28.25 | $195.71 | $67.38 | $320.25 | $203.75 |
| # AnalystsCovering analysts | 15 | 36 | 37 | 35 | 22 |
| Dividend YieldAnnual dividend ÷ price | +3.9% | +1.2% | +3.5% | +3.8% | +1.5% |
| Dividend StreakConsecutive years of raises | 4 | 14 | 1 | 6 | 32 |
| Dividend / ShareAnnual DPS | $1.01 | $1.93 | $1.63 | $10.92 | $2.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.8% | +1.6% | 0.0% | +0.3% | +0.3% |
CME leads in 1 of 6 categories (Income & Cash Flow). JKHY leads in 1 (Profitability & Efficiency). 4 tied.
BMRC vs ICE vs FIS vs CME vs JKHY: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BMRC or ICE or FIS or CME or JKHY a better buy right now?
For growth investors, Bank of Marin Bancorp (BMRC) is the stronger pick with 51.
8% revenue growth year-over-year, versus 5. 4% for Fidelity National Information Services, Inc. (FIS). Bank of Marin Bancorp (BMRC) offers the better valuation at 9. 5x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate Intercontinental Exchange, Inc. (ICE) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BMRC or ICE or FIS or CME or JKHY?
On trailing P/E, Bank of Marin Bancorp (BMRC) is the cheapest at 9.
5x versus Fidelity National Information Services, Inc. at 63. 0x. On forward P/E, Fidelity National Information Services, Inc. is actually cheaper at 7. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fidelity National Information Services, Inc. wins at 0. 31x versus Bank of Marin Bancorp's 2. 82x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BMRC or ICE or FIS or CME or JKHY?
Over the past 5 years, CME Group Inc.
(CME) delivered a total return of +64. 5%, compared to -63. 2% for Fidelity National Information Services, Inc. (FIS). Over 10 years, the gap is even starker: CME returned +284. 9% versus FIS's -13. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BMRC or ICE or FIS or CME or JKHY?
By beta (market sensitivity over 5 years), CME Group Inc.
(CME) is the lower-risk stock at -0. 30β versus Bank of Marin Bancorp's 0. 95β — meaning BMRC is approximately -413% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 70% for Intercontinental Exchange, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BMRC or ICE or FIS or CME or JKHY?
By revenue growth (latest reported year), Bank of Marin Bancorp (BMRC) is pulling ahead at 51.
8% versus 5. 4% for Fidelity National Information Services, Inc. (FIS). On earnings-per-share growth, the picture is similar: Bank of Marin Bancorp grew EPS 625. 0% year-over-year, compared to -47. 2% for Fidelity National Information Services, Inc.. Over a 3-year CAGR, JKHY leads at 6. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BMRC or ICE or FIS or CME or JKHY?
CME Group Inc.
(CME) is the more profitable company, earning 62. 0% net margin versus 3. 6% for Fidelity National Information Services, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 16. 5% for FIS. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BMRC or ICE or FIS or CME or JKHY more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Fidelity National Information Services, Inc. (FIS) is the more undervalued stock at a PEG of 0. 31x versus Bank of Marin Bancorp's 2. 82x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Fidelity National Information Services, Inc. (FIS) trades at 7. 5x forward P/E versus 23. 5x for CME Group Inc. — 16. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FIS: 42. 6% to $67. 38.
08Which pays a better dividend — BMRC or ICE or FIS or CME or JKHY?
All stocks in this comparison pay dividends.
Bank of Marin Bancorp (BMRC) offers the highest yield at 3. 9%, versus 1. 2% for Intercontinental Exchange, Inc. (ICE).
09Is BMRC or ICE or FIS or CME or JKHY better for a retirement portfolio?
For long-horizon retirement investors, CME Group Inc.
(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 30), 3. 8% yield, +284. 9% 10Y return). Both have compounded well over 10 years (CME: +284. 9%, BMRC: +41. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BMRC and ICE and FIS and CME and JKHY?
These companies operate in different sectors (BMRC (Financial Services) and ICE (Financial Services) and FIS (Technology) and CME (Financial Services) and JKHY (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BMRC is a small-cap high-growth stock; ICE is a mid-cap quality compounder stock; FIS is a mid-cap income-oriented stock; CME is a mid-cap income-oriented stock; JKHY is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.